17-8232440-C-T
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6
The NM_025099.6(CTC1):c.1981G>A(p.Val661Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000254 in 1,614,130 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_025099.6 missense
Scores
Clinical Significance
Conservation
Publications
- cerebroretinal microangiopathy with calcifications and cysts 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, G2P
- dyskeratosis congenitaInheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
- Coats plus syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_025099.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CTC1 | NM_025099.6 | MANE Select | c.1981G>A | p.Val661Ile | missense | Exon 12 of 23 | NP_079375.3 | ||
| CTC1 | NM_001411067.1 | c.1981G>A | p.Val661Ile | missense | Exon 12 of 21 | NP_001397996.1 | |||
| CTC1 | NR_046431.2 | n.1896G>A | non_coding_transcript_exon | Exon 12 of 22 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CTC1 | ENST00000651323.1 | MANE Select | c.1981G>A | p.Val661Ile | missense | Exon 12 of 23 | ENSP00000498499.1 | ||
| CTC1 | ENST00000581729.2 | TSL:3 | c.1981G>A | p.Val661Ile | missense | Exon 12 of 21 | ENSP00000462720.2 | ||
| CTC1 | ENST00000580299.2 | TSL:5 | c.1981G>A | p.Val661Ile | missense | Exon 12 of 21 | ENSP00000462607.2 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152150Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000882 AC: 22AN: 249436 AF XY: 0.0000665 show subpopulations
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1461862Hom.: 0 Cov.: 31 AF XY: 0.0000179 AC XY: 13AN XY: 727234 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152268Hom.: 0 Cov.: 32 AF XY: 0.0000806 AC XY: 6AN XY: 74450 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Cerebroretinal microangiopathy with calcifications and cysts 1 Uncertain:1
Dyskeratosis congenita Uncertain:1
This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 661 of the CTC1 protein (p.Val661Ile). This variant is present in population databases (rs534923467, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with CTC1-related conditions. ClinVar contains an entry for this variant (Variation ID: 529191). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt CTC1 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at